Literature DB >> 24016409

Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study.

Tevfik Guvenal1, Polat Dursun, Pinar S Hasdemir, Merih Hanhan, Suleyman Guven, Hakan Yetimalar, Behice P Goksedef, Derya K Sakarya, Arzu Doruk, Mustafa C Terek, Bahadir Saatli, Kadir Guzin, Aydin Corakci, Emek Deger, Husnu Celik, Ahmet Cetin, Aydin Ozsaran, Ayşe Ozbakkaloglu, Ali Kolusari, Cetin Celik, Refik Keles, Fulya G Sagir, Saffet Dilek, Turhan Uslu, Yilmaz Dikmen, Ozden Altundag, Ali Ayhan.   

Abstract

OBJECTIVE: The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging.
METHODS: In a retrospective Turkish multicenter study, 539 patients, from 14 institutions, with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan-Meier method.
RESULTS: The median age at diagnosis was 40 years (range 15-84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (73.5%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (54.5%) have undergone surgical staging procedures. Of the patients who underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1-120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival.
CONCLUSION: Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management.
© 2013.

Entities:  

Keywords:  Appendectomy; Borderline; Lymphadenectomy; Ovarian tumor; Surgical staging

Mesh:

Year:  2013        PMID: 24016409     DOI: 10.1016/j.ygyno.2013.08.038

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.

Authors:  Kevin M Elias; S Intidhar Labidi-Galy; Allison F Vitonis; Jason L Hornick; Leona A Doyle; Michelle S Hirsch; Daniel W Cramer; Ronny Drapkin
Journal:  Gynecol Oncol       Date:  2013-12-14       Impact factor: 5.482

2.  Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.

Authors:  Russell Vang; Charlotte G Hannibal; Jette Junge; Kirsten Frederiksen; Susanne K Kjaer; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

3.  A retrospective analysis of relapse-related factors for ovarian borderline tumors.

Authors:  Dan Ye; Haoran Shen; Wu Huang; Liangqing Yao
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

4.  Significance of lymph node ratio on survival of women with borderline ovarian tumors.

Authors:  David J Nusbaum; Rachel S Mandelbaum; Hiroko Machida; Shinya Matsuzaki; Lynda D Roman; Anil K Sood; David M Gershenson; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2020-04-17       Impact factor: 2.344

5.  Clinical Characteristics Predict Recurrence in Borderline Ovarian Tumor Patients with Fertility-Preserving Surgery.

Authors:  Yunan He; Jiaojiao Zhong; Hui Yang; Nianchun Shan; Anran Cheng
Journal:  Int J Gen Med       Date:  2022-02-26

6.  Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.

Authors:  Mehmet Gokcu; Kemal Gungorduk; Osman Aşıcıoğlu; Nilüfer Çetinkaya; Tayfun Güngör; Gonca Pakay; Zeliha Fırat Cüylan; Tayfun Toptaş; Ramazan Özyurt; Elif Ağaçayak; Aykut Ozdemir; Onur Erol; Anıl Turan; Varol Gülseren; Mehmet Sait İcen; Taylan Şenol; Hakan Güraslan; Burcu Yücesoy; Ahmet Sahbaz; Ozgu Gungorduk; Berhan Besimoğlu; Kaan Pakay; Osman Temizkan; Muzaffer Sancı; Tayup Şimşek; Mehmet Mutlu Meydanlı; Mehmet Harma; Levent Yaşar; Birtan Boran; Aysel Derbent Uysal; Ateş Karateke
Journal:  J Ovarian Res       Date:  2016-10-18       Impact factor: 4.234

7.  Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.

Authors:  Na Li; Jinhai Gou; Lin Li; Xiu Ming; Ting Wenyi Hu; Zhengyu Li
Journal:  BMC Cancer       Date:  2020-08-17       Impact factor: 4.430

8.  Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors.

Authors:  Ya Qi; Min Wang; Yuwei Yang; Zhi Zeng; Yingying Zhou
Journal:  J Cancer       Date:  2021-07-02       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.